A Quadratically Regularized Functional Canonical Correlation Analysis
  for Identifying the Global Structure of Pleiotropy with NGS Data by Lin, Nan et al.
1 
 
A Quadratically Regularized Functional Canonical Correlation Analysis for 
Identifying the Global Structure of Pleiotropy with NGS Data 
 
Nan Lin,1 Yun Zhu,2 Ruzong Fan3 and Momiao Xiong1,*  
1 Department of Biostatistics, School of Public Health, The University of Texas Health Science 
Center at Houston, Houston, TX 77225, USA. 
2Department of Epidemiology, Tulane University School of Public Health and Tropical 
Medicine, New Orleans, LA 70112, USA. 
3Biostatistics and Bioinformatics Branch (BBB), Division of Intramural Population Health 
Research (DIPHR), Eunice Kennedy Shriver National Institute of Child Health and Human 
Development, National Institutes of Health (NIH), Bethesda, MD 20892, USA. 
Present Address: Department of Biostatistics, School of Public Health, The University of Texas 
Health Science Center at Houston, P.O. Box 20186, Houston, Texas 77225, (Phone): 713-500-
9894, (Fax): 713-500-0900 
*Correspondence: Momiao.Xiong@uth.tmc.edu 
 
 
 
 
 
Running Title: Pleiotropic Analysis  
Key words: Pleiotropic analysis, multiple phenotypes, association analysis, functional canonic 
analysis, low rank model, quadratically regularized canonical analysis 
 
2 
 
Abstract 
Investigating the pleiotropic effects of genetic variants can increase statistical power, provide 
important information to achieve deep understanding of the complex genetic structures of 
disease, and offer powerful tools for designing effective treatments with fewer side effects. 
However, the current multiple phenotype association analysis paradigm lacks breadth (number of 
phenotypes and genetic variants jointly analyzed at the same time) and depth (hierarchical 
structure of phenotype and genotypes). A key issue for high dimensional pleiotropic analysis is 
to effectively extract informative internal representation and features from high dimensional 
genotype and phenotype data. To  explore multiple levels of representations of genetic variants, 
learn their internal patterns involved in the disease development, and overcome critical barriers 
in advancing the development of novel statistical methods and computational algorithms for 
genetic pleiotropic analysis, we proposed a new framework referred to as a quadratically 
regularized functional CCA (QRFCCA) for association analysis which combines three 
approaches: (1) quadratically regularized matrix factorization, (2) functional data analysis and 
(3) canonical correlation analysis (CCA). Large-scale simulations show that the QRFCCA has a 
much higher power than that of the nine competing statistics while retaining the appropriate type 
1 errors.  To further evaluate performance, the QRFCCA and nine other statistics are applied to 
the whole genome sequencing dataset from the TwinsUK study.  We identify a total of 79 genes 
with rare variants and 67 genes with common variants significantly associated with the 46 traits 
using QRFCCA. The results show that the QRFCCA substantially outperforms the nine other 
statistics. 
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Introduction 
     As of December 18th, 2014, a catalog of published Genome-Wide Association Studies 
(GWAS) had reported significant association of 15,177 SNPs with more than 700 traits in 
2,502  publications.1 It is reported that more than 4.6% of the SNPs and 16.9% of the genes 
were significantly associated with more than one trait2. These results demonstrate that genetic 
pleiotropic effects, which refers to the effects of a genetic variant affecting multiple traits, play 
a crucial role in uncovering genetic structures of correlated phenotypes.3-10 Most genetic 
analyses of quantitative traits have focused on a single trait association analysis, analyzing 
each phenotype independently.11  Less attention has been paid to comprehensive analysis of 
pleiotropic effects.12 However, multiple phenotypes are correlated due to shared genetic and 
environmental effects.13 The integrative analysis of correlated phenotypes which tests the 
association of a genetic variant with multiple traits often increases the statistical power to 
identify genetic associations and increases the precision of genetic effect estimation.13-16 It is 
increasingly recognized that the genetic effect can be detected only when the association of the 
genetic variant with the multiple traits are jointly tested.17 It is also noted that  directional 
pleiotropy widely exists. Changes of one trait may cause undesired changes of other traits. 
Investigation of pleiotropy provides a tool for designing the effective treatment with fewer side 
effects. 
     Two types of approaches can be used for genetic pleiotropic analysis. One approach is to 
utilize summary statistics for estimating genetic correlations and testing association of genetic 
variants with multiple traits17-21.  An alternative approach is to use individual genotypic 
information for association analysis of multiple correlated traits22.  The focus of this paper is to 
use individual genotypes for pleiotropic analysis. Three major types of methods are commonly 
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used to explore the association of genetic variants with multiple correlated phenotypes: 
multivariate techniques including multivariate linear models15, 23-32, linear mixed models16,32-34 
and functional linear models35, the combinations of univariate association measures for 
different phenotypes36-39, and dimension reduction methods including principal component 
analysis (PCA),14,40-43 and canonical correlation analysis.44-48  
     Statistical methods for testing the association of common variants with multiple traits have 
been well developed and successfully applied.49 The methods for pleiotropic analysis of rare 
variants are still under development.24,50  Next-generation sequencing and modern biosensing 
techniques have generated dozens of millions of SNPs and large numbers of clinical and 
intermediate phenotypes. The current multiple phenotype association analysis paradigm lacks 
breadth (the number of phenotypes and genetic variants jointly analyzed at a time) and depth 
(hierarchical structure of phenotype and genotypes). Most approaches perform analysis on the 
subsets of the full data space that are often missing, but now available. A key issue for high 
dimensional pleiotropic analysis is to effectively extract the informative internal representation 
and features from extremely high dimensional genotypic and phenotypic data. The statistical 
power of the methods that do not efficiently explore dimension reduction of both phenotype 
and genotype data will be limited. Despite their wide applications to the pleiotropic analysis, 
the current pleiotropic analysis methods share the same drawbacks. These methods, 
particularly multivariate analysis methods, either do not use data dimension reduction or ignore 
the rich linkage disequilibrium structure of genomic data when data dimension reduction is 
used. The most widely used methods for pleiotropic analysis are originally designed for 
analyzing a small number of phenotypes and common variant data.  Due to the lack of efficient 
analytic platforms, the current pleiotropic analysis methods have not been applied to large-
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scale real genetic pleiotropic analysis with a large number of phenotypes and next-generation 
sequencing (NGS) data.  To overcome these limitations and fully take the advantages of the 
genomic structure across a genomic region, we combine two approaches: (1) functional data 
analysis and (2) quadratically regularized CCA to develop a novel statistical method that is 
referred to as a quadratically regularized functional canonical correlation analysis (QRFCCA) 
for testing the association of genomic regions with multiple traits. The QRFCCA first 
transforms the high dimensional correlated discrete genotype data across the genes or genomic 
regions to a few regularized functional principal components in the low orthonormal 
eigenfunctional space by FPCA. Then, the QRFCCA will further utilize the quadratically 
recognized matrix factorization to project both the phenotype data and compressed genomic 
data by FPCA to low dimensional space with much fewer number of bases (components) than 
the traditional matrix factorization or PCA and changed distribution of eigenvalues in which 
the proportion of top eigenvalues substantially increases. The QRFCCA dramatically reduces 
the dimensions of both genotype and phenotype data while fully retaining the original 
genotypic and phenotypic information. 
   To evaluate the performance of the developed QRFCCA for association analysis of multiple 
phenotypes, we conduct large-scale simulations comparing QRFCCA to nine statistics: Sparse 
CCA (SCCA),53  GAMuT24,  FCCA51, kernel CCA (KCCA)89,   CCA, A Unified Score-Based 
Association Test (USAT)54,  PCA (applying to both phenotypes and genotypes), MANOVA 
(multivariate ANOVA applied to multiple phenotypes and SNPs), and minP (minimum of P-
values for testing the  association of single SNP with multiple phenotypes)  and demonstrate that 
the QRFCCA has a much higher power than other competing statistics while retaining the correct 
type 1 error rates. Finally, the QRFCCA and nine other statistics are applied to the whole 
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genome sequencing dataset from the TwinsUK study where 756 individuals with 33,746 genes 
and 46 traits in 13 major phenotype groups are included in the analysis. We find that the 
QRFCCA for pleiotropic analysis substantially outperforms the nine other statistics.  A program 
for implementing the developed QRFCCA for association analysis of multiple phenotypes can be 
downloaded from our website http://www.sph.uth.tmc.edu/hgc/faculty/xiong/index.htm. 
Material and Methods 
     To efficiently explore the organized genomic structure information in the data, the proposed 
QRFCCA for pleiotropic genetic analysis considers three levels of representation of genomic 
data within a gene or genomic region: (1) functional principal component representation, (2) 
matrix factorization and (3) quadratic regularization.  In addition, there are two levels of 
representations of the unorganized phenotype data: (1) matrix factorization and (2) quadratic 
regularization. Genotype-phenotype association attempts to unravel the relationships between 
certain combinations of genetic variants from multiple loci and certain combinations of 
multiple phenotypes. The CCA measures the linear relationships between two 
multidimensional sets of variables and hence will be naturally used as a general framework for 
identifying the association between genotypes and phenotypes.  
Smooth Functional Principal Component Analysis 
For the self-contained, we briefly introduce the smooth functional principal component 
analysis (FPCA) for genetic variant data55.  We first review the definition of genetic variant 
profiles. Let t be the position of a genetic variant within a genomic region and T be the length of 
the genomic region being considered. For convenience, we rescale the region from ],0[ T  to ]1,0[ . 
We can view t  as a continuous variable in the interval ]1,0[  because the density of genetic 
variants is high, We define the genotype of the i-th individual as  
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where M is an allele at the genomic position t  and n is the number of sampled individuals.  
     To capture the variation of the genetic variant function, we define a linear combination of 
functional values: 
 dttXtf 
1
0
)()( , (2) 
where )(t  is a weight function and )(tX  is a centered genetic variant function defined in 
equation (1). The functional principal components can be obtained by choosing the weight 
function )(t  to maximize the variance of f : 
  
1
0
1
0
)(),()()( dsdtttsRsfVar  ,       (3) 
where ),( tsR is the covariance function of the genetic variant function )(tX .  
     To improve the smoothness of the estimated functional principal component curves, we 
impose the roughness penalty on the functional principal component weight functions. The 
balance between the goodness-of-fit and the roughness of the function is controlled by a 
smoothing parameter  .  The smoothed functional principal components (FPCs) can be obtained 
by solving the following integral equations: 
 
1
0
4 )].()([)(),( tDtdsstsR         (4) 
Let ,...2,1),( jtj be a set of FPCs. The genotype profile function )(txi can be expanded in 
terms of orthogonal FPCs: 
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where ij is the FPC score of the 
thi  individual which can be estimated by 
 , kj ,...,2,1 ,        (6) 
where  . is the inner product defined as 
, where .   
Matrix Factorization  
   Consider a data matrix qnRA  consisting of n samples with q features (variables). The data 
matrix A  represents the genotype data, the FPC scores or the phenotype data. The phenotype 
data include both continuous and discrete values. The thi row of A  is a vector of q  features for 
the thi sample, and the thj   column of A is a vector of the thj  feature across the set of n samples.  
Matrix factorization is used as a general framework to embed the genetic and phenotype data 
into the low dimensional vector space to reduce the data dimension and remove anomalous or 
noise data points56.  To accomplish this, we first seek the best rank- l approximation to the matrix 
A  by factorizing it into a product of two low rank matrices. 
     Let lnRG  and qlRH  . Assume that the rank of A  is r . Therefore, ),min( qnr  .  Matrix 
factorization attempts to minimize the approximation error: 
2
,
||||min F
HG
GHA     ,          (7) 
where 
F||.|| denotes the Frobenius norm of a matrix. 
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Let 
l
i Rg
 1 be the thi row of G , lj Rh  be the 
thj   column of H  and 
ij
A be the value of the  thj  
feature in the thi sample. Define ijji GHhg )( as an inner product. The objective function in 
problem (7) can be rewritten as 
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2)( .         (8) 
A solution to problem (7) can be found by truncating the singular value decomposition (SVD) of 
ij
A .56  Let the SVD of A be given by 
TVUA  ,           (9) 
where  rnr RuuU
 ],...,[ 1 , 
rq
r RvvV
 ],...,[ 1 , rr
T
rr
T IVVIUU   , , and 
rr
r R
 ),...,( 1  diag with 0...21  r . The columns of U and V  are referred to as 
the left and right singular vectors of A , respectively, and 
r ,...,1 are referred to as the singular 
values of A .  
    Substituting equation (9) into equation (7) gives  
2
,
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which can be reduced to 
2
,
||||min F
T
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GHVU     .         (10) 
Let GHVUZ T and the rank of Z be l .  Then, we have 
    
r
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     To minimize 2|||| FZ , it must be liZjiZ iiij  ,0,,0 and liZ iii ,...,1,   . In 
other words, the matrix which minimizes equation (11) should be 
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where ),...,( 1 ll  diag . The error of l -rank matrix approximation to A is  
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As a consequence,  
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where ],...,[ 1 ll uuU   and ],...,[ 1 ll vvV  .  
Define 
2/1
llUG   and ll VH
2/1 .  The matrix factorization of A is then given by 
GHA .           (15) 
Canonical Correlation Analysis  
An alternative to multivariate linear regression analysis, the CCA is a popular analytic 
platform for genetic pleiotropic analysis. The goal of CCA is to seek optimal correlation between 
linear combinations of two sets of variables: the set of traits and the set of SNPs. The CCA 
measures the strength of association between the multiple SNPs and the traits. The pairs of linear 
combinations are called canonical variates and their correlations are called canonical 
correlations57.  
Consider a phenotype matrix 
],...,[ 1 kYYY    with k traits and genotype matrix  
],...,[ 1 pXXX   
with p  SNPs or FPC scores. We assume that kp  variables TTT YXZ ],[ jointly have the 
covariance matrix  
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We denote linear combinations of the matrices X and Y  by 
YBvXAu     , .          (16) 
In a matrix form, CCA can be formulated as 
.  ,        s.t.
Tr     
IBBIAA
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        (17) 
Let  
2/112/12   YYXYXXYXYYR ,          (18) 
2/12/1   YYXYXXK  and  the SVD of K be 
TVUK  ,           (19). 
where ),...,( 1 qdiag  and ),min( kpq  is the smaller number of variables in the two 
genotype-phenotype datasets.  It is clear that 
TT VVRKK 22  . 
It is well known that the canonical vectors are 
,
,
2/1
2/1
VB
UA
YY
xx




           (20) 
and the vector of canonical correlations are 
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T
qCC ],...,[ 1  .           (21) 
A squared canonical correlation measures the proportion of variance linearly shared by the two 
sets of canonical variates derived from the input genotype-phenotype data sets. 
Canonical correlations between the genotype and phenotypes measure the strength of their 
association.  The CCA produces multiple canonical correlations. But we wish to use a single 
number to measure the association of the genetic variation with the multiple traits. We propose to 
use the summation of the square of the singular values as a measure to quantify the association of 
the genetic variation within a gene or genomic region with the multiple traits: 
)(Tr)(Tr 22
1
2 Rr
q
i i
   .        (22) 
To test the association of the genetic variation in a gene or genomic region is equivalent to test 
independence between the two genotype-phenotype datasets X and Y or to test the hypothesis 
that each variable in the set X is uncorrelated with each variable in the set Y .  The null 
hypothesis of no association of the genotype data X with the phenotype dataset Y can be 
formulated as 
0:0  xyH . 
The likelihood ratio for testing 0:0  xyH is 
)1(
||||
||
1
2  

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q
i i
yyxx
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r  ,        (23) 
which is equal to the Wilks’ lambda   defined in the multivariate linear regression model. 
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This demonstrates that testing for association using multivariate linear regression can be treated 
as special case of CCA61. 
    We usually define the likelihood ratio test statistic for testing the association as: 
)1log(
1
2  
q
i iCCA
NT  .         (24) 
For small 
2
i , CCAT  can be approximated by NrN
q
i i
 1
2 , where r is the measure of 
association of the genetic variation in the gene or genomic region with the multiple traits. The 
stronger the association, the higher the power that the test statistic can test the association.  
Under the null hypothesis 0:0  xyH , CCAT is asymptotically distributed as a central
2
pk  . When 
sample size is large, Bartlett (1939) suggests using the following statistic for hypothesis testing: 
)1log(]
2
)3(
[
1
2  


q
i iCCA
q
NT  .       (25) 
Quadratically Regularized Matrix Factorization and Canonical Correlation Analysis 
   The power of the test statistics in CCA depends on the squared canonical correlations or 
eigenvalues of the matrix 2R .  We wish to increase the power via changing distribution of the 
canonical correlations and data reduction. In matrix factorization, for fixed rank l , we want to 
approximate the matrix A by the product of two factor matrices G and H as accurately as 
possible. However, the Frobenius norm of the matrices G and H may be large. We need to 
balance the approximation accuracy and the Frobenius norm of the factor matrices. Specifically, 
we add the Frobenius norm of the factor matrices to the objective in equation (7). The 
optimization problem (7) is now transformed to the quadratically regularized matrix factorization 
problem: 
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From equation (15), the matrices G and H have the forms: 
2/1
llUG   and ll VH
2/1 .           (27) 
Substituting equation (27) into equation (26) gives 
)(2||||min 2 lFlF
l


Tr      ,        (28) 
where  ),...,( 1 kdiag  and )0,...,0,,...,( 1 ll diag . 
Expanding the Frobenius norm of the matrices,  problem (28) can be further reduced to 
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To minimize F , we set  
02)(2 

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jj
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F
.         (30) 
Solving equation (30) for j yields 
  jj .           (31) 
To ensure that the factor matrices are non-negative, j must be non-negative. Thus, we have the 
solution: 
 )(  jj ,          (32) 
where  )0,max()( aa  . 
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Define the matrix l as 
))(,...,)(( 1    ll diag . 
Then, factor matrices 
2/1
llUG   and ll VH
2/1  are the solution to the minimization problem 
(26). We use truncation of the SVD to keep only the top l singular values and soft-thresholding 
on the singular values to change distribution of the singular values. When  increases beyond 
some singular values m , 1ml singular values of GH will disappear.  Analytically, we can 
easily show that 
ll 







...... 21
1
21
1 .  
In other words, increasing  will move up the proportion of the first singular value in the total of 
singular values. The phenotype data consist of 756 samples with 46 traits. The initial largest 
singular value and total singular values of the phenotype data are 73.97 and 1030.14 
respectively. Figure S1 shows that the proportion of the first singular value in the total of 
singular values is an increasing function of threshold  . This clearly demonstrates that adding 
quadratic regularization results in changing the distribution of the singular values of the factor 
matrices. Therefore, we can expect that regularized matrix factorization for data reduction will 
increase the power to detect association of the genetic variation with the traits.  
      Quadratically regularized matrix factorization and CCA have broad applications. There are a 
number of ways to use the quadratically regularized matrix factorization for data reduction in the 
association analysis which are briefly summarized as follows. 
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(1) Continuous phenotypes and NGS genotype data (dimension reduced genotype data using 
FPCA-gene-based association study). 
      We can first apply the quadratically regularized matric factorization to both multiple 
phenotype data and FPC score data in a gene or genomic region and then use CCA for 
association analysis of multiple traits. This analysis will be referred to as quadratically 
regularized FCCA (QRFCCA) for multiple trait association analysis. If only a single trait is 
considered, the quadratically regularized matrix factorization is only applied to the FPC score in 
the gene.  
(2) Continuous phenotypes and multiple SNPs. 
Quadratically regularized matrix factorization is first applied to both multiple phenotypes and 
SNPs for data reduction and then CCA is used for multiple trait association analysis. This 
procedure is referred to as QRMCCA.  
(3) Continuous phenotypes and a single SNP. 
Quadratically regularized matrix factorization is first applied to multiple phenotypes and then 
CCA is used for multiple trait association analysis. This procedure is referred to as 
QRSCCA. 
(4) Both functional phenotype such as RNA-seq data and functional genotype data such as NGS 
data. FPCA is first applied to both functional phenotype and genotype data to obtain FPC 
scores for both phenotypes and genotypes. Quadratically regularized matrix factorization is 
applied to FPC scores of both functional phenotype and genotype data. Finally, CCA is used 
for multiple trait association analysis. This procedure is referred to as QRBFCCA. 
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Quadratically recognized matrix factorization can also be applied to the K or 2R matrix in the 
CCA. The test statistics then use the singular values of the reduced K or 2R matrix to test 
association of genetic variation with a trait.  
Connection between CCA and Maximum Heritability Analysis 
     Next we study the relationships between the CCA and the traditional quantitative trait 
analysis.  For simplicity, we assume that the genetic variation is the only major contribution to 
the phenotypic variation and we will not consider the covariates. For the single trait, in 
Supplemental note A, we show that the narrow heritability can be expressed as the proportion of 
the phenotype variation explained by the genetic variation or the squared correlation between the 
genotype and phenotype. 
     Now we consider the multiple traits. We assume that the multivariate linear model for the 
multiple traits is given by 
 XBY ,           (33) 
where X is a genotype matrix and ],...,[ 1 kbbB  is the regression coefficient matrix or genetic 
effect matrix. 
The genetic effect matrix can be estimated by 
xyxxB 
1ˆ .           (34) 
The covariance of the genetic additive effects is defined as (Supplemental note A, N7) 
xyxxyxA 
1
.          (35) 
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The concept of heritability for a single trait is well developed. Recently, there has been 
increasing attempts to extend heritability from a single trait to multiple traits. However, the focus 
is to consider the heritability of a linear combination of multiple traits50,59,60.  Here, we consider a 
heritability matrix that is defined as 
2/112/12   yyxyxxyxyymh ,   .      (36) 
which is equal to the matrix 2R in the CCA (equation 18). 
Let 
2/12/1   yyxyxxK  and SVD of K be 
T
KKKyyxyxx VU 
 2/12/1
.         (37) 
In Supplemental note A, we show that the maximum heritability analysis is equivalent to CCA.  
The optimal linear combination coefficients are given by 
, kyy
kxx
vb
ua
2/1
2/1




              (38) 
where ku  and kv  are the left and right singular vectors  of the matrix K , respectively. 
In Supplemental note A, we show that the genetic additive effect and genetic additive variance 
are, respectively, given by (N19) 
, bb
Kvu
xyxxyx
T
KAl
KK
T
K


1222 ˆ
ˆ


        (39) 
where 
K is the singular value of the matrix K  and 
2
K is the eigenvalue of the matrix 
22/112/1 RKK yyxyxxyxyy
T   .        (40) 
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The narrow-sense heritability is 
22
Klh  ,           (41) 
which is the square of  canonical correlation. This shows that the maximum heritability analysis 
is equivalent to CCA.  
Relationship among CCA,  Kernel CCA, Functional CCA, Cross-covariance operator, 
Dependence Measure and Other Association Tests 
In supplemental note B, we use reproducing kernel Hilbert spaces (RKHS) as a general 
framework and the covariance operator as a general tool for unifying CCA, kernel CCA, 
functional CCA and other association analyses including GAMuT.  Many multivariate and 
functional statistical methods such as regression, CCA, kernel regression, kernel CCA, 
functional regression and functional CCA can be used to test the association of genetic variants 
with the phenotypes. In the past decades, reproducing kernel Hilbert spaces (RKHS) have 
emerged as a general framework for various statistical and machine learning methods. In 
supplemental note B, we use RKHS as a unified framework for association tests to reveal the 
relationships among various multivariate and functional association tests.  
Covariance is a key measure for assessing association. In Supplemental Note B, we extend 
covariance between two random variables in the original probability space (N24): 
][
~ T
XY XYE           (42) 
to the feature space (N25) 
)]()([
~
YXE TXY  ,         (43) 
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where )(X and )(Y are feature maps and XY
~
is referred to as a covariance operator. We then 
show that 
)],()(([
~
YgXfEgf XY
T           (44) 
where f and g are vectors in the feature space.  We show that (N33) 
 yx
T
XY
T KK
m
gf
~~1
 ,         (45) 
where TYXXYXY 
~
, mmjix XXKK  )),(( , mmjiy YYKK  )),(( , mm
m
IG 1
1
 ,
GGKK xx 
~
 and GGKK yy 
~
. 
Solving the optimization problem (N34) leads to the dependence measure (N39): 
)
~~
( Trace
1
2 yyxx
KK
m
,          (46) 
which is the basis for the GAMuT test.24  In Supplemental note B, we show that the KCCA is 
quite similar to the kernel independent test and if the constraints in (N40) in the KCCA  are 
replaced by 1
~
)(   x
T KUVar and 1
~
)var(   y
T KV , then the association measure in the 
KCCA is equal to  
)
~~
( Trace
1
)(Tr
1
2
2
2 yyxx
KK
mm
 , 
which is exactly equal to the dependence measure.  
    Finally, we consider the FCCA.  To unify multivariate association tests and functional 
association tests, we use RKHS as a general framework for formulation of the functional CCA.1 
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Consider two index sets 
1E and 2E , and two stochastic processes: }),({ 1EttX  and 
}),({ 2EssY   with mean zero 0)](()]([  sYEtXE for all st, , auto covariance functions  
)),(),(cov(),( 2121 sXsXssRX    ))(),(cov(),( 2121 tYtYttRY   and cross covariance functions 
))(),(cov(),( tYsXtsRXY  . 
Let 2XL and 
2
YL be the Hilbert spaces spanned by the X and Y processes. Let  )( XRH  be RKHS 
generated by the covariance kernel 
XR  and  )( YRH  be RKHS generated by the covariance 
kernel 
YR . The canonical correlation can be defined in terms of both 
2
XL and 
2
YL , and )( XRH and 
)( YRH : 
)),(),((cov    max
),(cov             max
2
1||||,1||||
)(),(
2
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,
2
)(
2
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where )(X  and )(Y are the congruence mapping from )( XRH to 
2
XL and )( YRH to 
2
YL , 
respectively. 
We show that formulation of FCCA in equation (N65) is equivalent to the formulation of the 
FCCA in the 22 , YX LL  and )(),( YX RR HH as expressed in equation (47).  Therefore, the FCCA 
can be defined as (N65) 
,1,1       s.t.
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,





YY
T
XX
T
XY
T
        (48) 
where  
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We show that the association measure r of the FCCA is given by 
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.       (49) 
If constraints 1,1   YY
T
XX
T  in equation (38) is replaced by 1 T  and 1 T , 
i.e., the optimization problem (48) is reduced to 
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then equation (49) is reduced to 
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Suppose that the FPC scores form a feature space. In supplemental note B, we define the feature 
maps from the original functional data to the FPC score feature space. We show that the 
dependence measure in the FPC score-based kernel analysis is asymptotically equal to the 
association measure of the FCCA. This implies that the FCCA is a specific kernel analysis that 
uses the FPC score to define the kernels instead of directly using the genotype data to define the 
kernels.          
Results 
Null Distribution of Test Statistics 
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     To examine the null distribution of test statistics for association analysis of multiple traits, we 
performed a series of simulation studies to compare their empirical levels with the nominal ones. 
We calculated the type I error rates for rare alleles, and both rare and common alleles. We first 
assumed the model for multiple traits:  
iiY   , ,,...,1 ni    
where ],...,[ 1 ikii yyY   k is the number of traits,  is an overall mean, and i is distributed as  
),0( N , where   is a kk  residual correlation matrix. We similarly model the correlation 
matrix as in Broadaway et al24. We also consider three scenarios of low residual correlation 
among phenotypes with pair-wise correlation selected from a uniform (0.1, 0.2) distribution, 
moderate residual correlation with pair-wise correlation selected from a uniform (0.2, 0.4) 
distribution, and high  residual correlation with pair-wise correlation selected from a uniform 
(0.4, 0.7) distribution.  
     We randomly generated 1,000,000 haplotypes with gene C16orf62 from 659 samples of 
European origin in The 1000 Genome Project. 1,000 SNPs with 600 rare variants (frequencies 
ranging from 0.0005 to 0.01) and 400 common variants (frequencies larger than 0.01) were 
randomly selected from C16orf62 gene. The number of sampled individuals for type 1 error 
simulations from populations of 500,000 individuals ranged from 500 to 2,000. A total of 10,000 
simulations were repeated.  The type 1 error rates were estimated as the proportion of the 
datasets under the null distribution in which the P-values were less than or equal to the 
significance level.  
     Tables 1 and 2  summarized the type 1 error rates of the ten statistics: QRFCCA, Sparse CCA 
(SCCA)53, GAMuT,  FCCA, Kernel CCA (KCCA),  CCA, A Unified Score-Based Association 
Test (USAT)54, PCA (applying to both phenotypes and genotypes), MANOVA (multivariate 
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ANOVA applied to multiple phenotypes and multiple SNS) and minP (minimum of P-values for 
testing the  association of single SNP with multiple phenotypes) for testing the association of 
rare variants, and both rare and common variants, within a genomic region with 15 high 
correlated traits, respectively, at   the nominal levels α=0.05, α=0.01 and α=0.001. Tables S1-S16 
showed type 1 error rates of the ten statistics for testing the association of rare variants, and both 
rare and common variants with 5, 10 and 15 traits under three scenarios: low, moderate and high 
correlations. These tables showed that the estimated type 1 error rates of the QRFCCA across a 
range of assumptions were not appreciably different from the nominal levels ,  
and . We also observed that the type 1 error rates of other nine statistics, in most 
scenarios, were appropriate. 
Power Evaluation 
To evaluate the performance of the QRFCCA in association analysis, we used simulated data to 
estimate power of ten statistics for testing the association of a gene or a genomic region with the 
traits. We simulated 5, 10 and 15 traits with low, moderate and high correlations. An additive 
genetic model was used to summarize all genetic effects of causal variants in the gene or 
genomic region.  
     For each individual, 5, 10, 15 quantitative traits were simulated by the summation of genetic 
effect and the residual correlation between the traits. Let 
2
kh be the narrow heritability of the 
thk  
trait. Assume that each SNP had a %2 chance to be associated with a trait and its genetic effect 
on the thk  trait was equal to the 
MAF
hk
2
multiplied by the number of minor alleles where MAF
denoted the frequency of the minor allele. This indicates that the genetic effect of causal variants 
05.0 01.0
001.0
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was inversely proportional to its minor allele frequency. Therefore, we assumed that the very 
rare variants had larger genetic effects than less rare variants.  
We did not assume that the gene of interest was associated with all traits. In fact, we assumed 
that the gene of interest was truly associated with three of five assessing traits, six of ten 
assessing traits and eight of 15 assessing traits. The residual correlation was simulated from a 
multivariate distribution with mean zero and covariance matrix 
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where the correlation between traits ijr was randomly generated with uniform distribution: low 
correlation ]2.01.0[  , moderate correlation ]4.02.0[   and high correlation ]7.04.0[  . In 
summary, the genetic model for power evaluation is given by 
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where iy represented phenotypes, jx was an indicator variable for coding the genotype of the 
thj  SNP in the gene, taking values 0, 1, 2 to represent the number of minor alleles at the SNP. 
ij denoted the genetic effect that followed a normal distribution with ),0(
2
j
i
MAF
h
N , where 
2
ih
denoted the narrow heritability of the thi trait, jMAF denoted the frequency of the minor allele at 
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the 
thj SNP, ijb in the matrix represented the probability of the 
thj SNP being the causal variant 
for the thi trait and followed a binomial distribution )02.0,1(B . Notation denoted an element-
wise matrices multiplication, )6.0,1(~ Bti represented the probability of the gene being tested 
contributing the genetic effect to the thi trait and 
2
ih denoted the heritability of the 
thi trait and 
followed a uniform distribution )015.0,005.0(U , Kii ,...,1,  denoted residuals and followed a 
multivariate normal distribution as defined above.  
    The genotype data in type 1 error calculations were also used for power evaluation.  A total of 
10,000 simulations were repeated for the power calculations. 
We first compared the power of QRFCCA with nine other competing statistics that are 
described in type 1 error rate calculations for testing the association of rare variants with multiple 
continuous traits. Power was estimated as a function of sample sizes.  Figures 1-3 plotted the 
power of the curves as a function of sample sizes of the ten statistics for collectively testing the 
association of all rare variants in the gene with 10 low, moderately and highly correlated traits, 
respectively, at the significance level 05.0  . The power curves of ten statistics for testing the 
association of the gene including only rare variants with 5 and 15 low, moderately and highly 
correlated traits, respectively, were plotted in Figures S2-S4, Figures S5-S7.   We observed 
several remarkable features. First, we clearly observed that the QRFCCA had highest power 
among all ten statistics, followed by SCCA for all scenarios considered. Second, in general, the 
power of the FCCA was higher than that of the KCCA and the GAMuT, but their differences 
were very small. Third, we often observed that the functional data analysis-based and kernel-
based methods had higher power than the classical multivariate methods.  
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Next we investigated whether the power pattern of the ten statistics for testing the association 
of the gene with only rare variants would still hold when testing the association of the gene with 
both rare and common variants.  Figures 4-6 presented the power curves of ten statistics for 
testing the association of the gene including both rare and common variants with 10 low, 
moderately and highly correlated traits at the significance level 05.0 , respectively. Figures 
S8-S10, and S11-S13 showed the power curves of the ten statistics for testing the association of 
the gene including both rare and common variants with 5 low, moderately, and highly correlated 
traits, and 15 low, moderately, and highly correlated traits, respectively. We observed the similar 
power pattern of the tests for both rare and common variants as that for only rare variants. These 
figures demonstrated that the QRFCCA substantially outperformed the nine other statistics and 
the difference in power between the QRFCCA and other statistics for the both rare and common 
variants was much larger than that for the rare variants only. This demonstrated that the 
regularization in singular vectors plays a more important role in association analysis of both rare 
and common variants than that in association analysis of only rare variants.  
 
 Application to Real Data Examples 
Investigation of the contribution of the entire allelic spectrum of genetic variation to multiple 
traits are still at its infancy.   The systematic searching for both common and rare variants 
associated with large number of traits is essential for unraveling the genetic architecture of 
complex diseases.  To further evaluate the performance, the QRFCCA and nine other statistics 
were applied to the UK-10K dataset. The UK10K Cohorts project used a low read depth whole-
genome sequencing (WGS) to assess the contribution of the genetic variants to the sixty-four 
different traits.62 However,  missing phenotypes were found in many individuals. To ensure no 
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missing phenotypes in individuals, we included 765 individuals with 2,240,049 SNPs in 33,746 
genes, and shared 46 traits in 13 major phenotypic groups which covered a wide range of traits 
(Table S17) in the analysis.  We took the rank-based inverse normal transformation of the 
phenotypes63 as trait values.   
     We first studied the association of genes with only rare variants (MAF 01.0 ). The total 
number of genes with only rare variants tested for association was 33,746. A p-value for 
declaring significant interaction after applying the Bonferroni correction for multiple tests was
61048.1  . To examine the behavior of the test statistics, we plotted the QQ plot of the 
QRFCCA with one FPC, FCCA with one FPC, PCA and GAMuT using a linear kernel in Figure 
7 and the QQ plot of the KCCA, SCCA, CCA, MANOVA and USAT in Figure S14.  The QQ 
plots showed that the false positive rate of the QRFCCA and FCCA for testing the association of 
the gene with 46 traits in some degree was controlled. However, the behavior of the QQ plot of 
KCCA and SCCA was weird.  
     The total number of genes significantly associated with the 46 traits using QFCCA, FCCA, 
PCA, SCCA, KCCA, GAMuT, CCA, USAT and MANOVA, were 79, 59, 14, 8, 3, 0, 0, 0 and 0, 
respectively (Table 3, Table S18).  We observed that the list of 79 significant genes identified by 
QFCCA included all 59 significant genes using FCCA, all 8 significant genes using SCCA, all 3 
significant genes using KCCA and  8 significant genes using PCA.   The Manhattan plot 
showing genome-wide p-values of association with 46 traits calculated using QRFCCA is 
presented in Figure 8.  
     To further assess the performance of the QFCCA and GAMuT, we presented Tables S19 and 
S20. Table S19 summarized the top ten genes ranked using GAMuT where p-values calculated 
by both GAMuT and QRFCCA were also listed. None of ten genes reached genome-wide 
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significance levels by the GAMuT.  However, we noticed that 7 of top ten gens ranked by 
GAMuT were significantly associated with the 46 traits identified by QFCCA.  Although we 
observed that the p-value of RNU6-1229P calculated by GAMuT was smaller than that 
calculated by QRFCCA, we did not find any significant SNPs within RNU6-1229P (Figure S15).  
This may imply that association was spurious. In Table S20, we listed p-values of all SNPs 
within gene ADAM19. We observed that QRFCCA identified significance of ADAM19 with a p-
value less than 111007.6     and at least 4 SNPs in ADAM19 had very small p-values and two 
additional SNPs had p-values that were close to the threshold p-value of genome-wide 
significance (Figure S15). However, the GAMuT missed to identify significance of ADAM19.  
    To characterize the pleotropic pattern, we presented the heat map showing the pattern of cross 
phenotype association of genes with rare variants only and the most important pleiotropic effects 
of the genes (Figure 9). Table S21 summarizes the number of traits which a single gene was 
associated with (p-value )05.0 . In Table S21, we also listed the p-values for testing the 
association of the gene with all 46 traits. All p-values in Figure 9 and Table S21 were calculated 
using QRFCCA. We observed two remarkable features. First, we observed that 5 genes were 
significantly associated with 3 traits, 10 genes were significantly associated with 2 traits, and 39 
genes were significantly associated with one trait at the genome-wide significance level after 
Bonferroni correction.  The remaining 25 genes did not reach the genome-wide significance with 
any trait. However, we observed that these genes still showed mild association with multiple 
traits. Second, we observed that multiple genes were significantly associated with single 
phenotype (Table S22). For example, 345 genes were significantly associated with creatinine, 
108 genes with HOMA-IR, 20 genes with HOMA-B, 72 genes with  HsCRP, 21 genes with 
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glucose, 15 genes with insulin, 14 genes with GGT, 11 genes with triglycerides and 11 genes 
with VLDL.  
Some results can be confirmed in the literature. Throughout this section, all p-values were 
calculated using QRFCCA.  PNOC which was associated with the 46 traits (p-value 
121063.1  ),  HOMA-IR (p-value 7102.1  ) and  triglycerides (p-value 91015.9  )  was 
reported to be associated with insulin resistance64 and triglycerides.65  MIR409 which was 
associated with the 46 traits  (p-value 101077.2  ), weight (p-value 61065.1  ), Hip (p-
value 71019.7  ) and total lean mass (p-value 61015.2  ) was used as a weight loss  
biomarker.66  GAPDH which showed an association with the 46 traits (p-value 81096.2  ) and 
specifically with creatinine (p-value 81045.3  ) was reported to be associated with 
creatinine.67  MLN which demonstrated association with the 46 traits (p-value 81047.9  ) and 
showed a strong association with glucose (p-value 111024.6  ) played an important role in 
controlling the rise rate of glucose level.68  JUN,  which was associated with the 46 traits (p-
value 71025.1  ) and showed a strong association with creatinine (p-value 201043.3  ), 
was reported to be correlated with the serum creatinine level.69  COMP which showed 
significance with the 46 traits p-value 71083.4  ) and a strong association with specific trait 
creatinine (p-value 151058.9  ) was also reported an association with creatinine.70   
     Next we studied the association of genes with only common variants (MAF )05.0 . The total 
number of genes with only common variants tested for association was 33,166. The p-value to 
declare the significant association after applying Bonferroni correction for multiple tests was
61051.1  . To examine the behavior of the test statistics, we plotted the QQ plot of the 
QRFCCA, FCCA, PCA and GAMuT using a linear kernel in Figure 10 and the QQ plot of the 
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KCCA, SCCA, CCA, MANOVA and USAT in Figure S16.  Similar to rare variants, the QQ 
plots for common variants showed that the false positive rate of the QRFCCA and FCCA for 
testing the association of the gene with 46 traits in some degree was controlled. However, the 
behavior of the QQ plot of KCCA and SCCA was weird.  
    The total number of genes significantly associated with the 46 trait using QFCCA, FCCA, 
PCA, SCCA, KCCA, GAMuT, CCA, USAT and MANOVA, were 67, 55, 0, 0, 31, 0, 0, 0 and 0, 
respectively (Table 4, Table S23).  Similar to rare variants, we observed that a list of 67 
significant genes identified by QFCCA included all the 55 significant genes identified using 
FCCA. However, unlike rare variants, only one significant gene was shared between the 
QRFCCA and KCCA. To assess whether the QRFCCA for testing the association of genes 
including common variants only with multiple traits was appropriate or not, we presented Figure 
S17 which shows the p-values of all SNPs within gene REG1B. We observed in Figure S17 that 
more than 11 SNPs in REG1B with p-values 0001.0  jointly made contributions to the strong 
association of REG1B with the 46 traits with p-value 1161065.1  . The QRFCCA can catch the 
features of genetic variation. In Figure S17 we listed the p-values of all SNPs within the gene 
XXbac-BPG154L12.4. From Figure S17, we also observed that although the GAMuT treated 
XXbac-BPG154L12.4 as associated with the 46 traits (p-value 61055.2  ), none of SNPs  
were even weakly associated with the 46 traits. We should point out that the QRFCCA did not 
find any, even mild association (p-value )3175.0 .  The Manhattan plot showing genome-wide 
p-values of association of genes consisting of only common variants with the 46 traits calculated 
using QRFCCA is presented in Figure 11.  
To unravel the genetic pleotropic structure of common variants, we presented the 
gene/phenotype association heat map that demonstrated the most important pleiotropic relations 
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between a single gene and multiple traits (Figure 12) and summarized the number of traits a 
single gene affected in Table S24.  All p-values in Figure 12 and Table S24 were calculated 
using QRFCCA. We observed that one gene significantly influenced 6 traits; 2 genes, 5 traits; 4 
genes, 4 traits; 6 genes, 3 traits; 17 genes, 2 traits and 20 genes, one trait. The remaining 17 
genes did not reach the genome-wide significance with any trait. However, we observed that 
these genes still made genetic contributions to multiple traits. The significant association of the 
remaining 17 genes with the 46 traits was due to summation of the mild genetic effects on 
multiple traits of a single gene.  
We also analyze the association of all common SNPs in one gene and one trait for all the 46 
traits. The results were summarized in Table S25.  We observed that 34 genes were significantly 
associated with creatinine, 29 genes with HsCRP, 23  genes with HOMA-IR, 23 genes with 
HOMA-B,  9 genes with glucose, 8 genes with insulin, 7 genes with GGT, 6 genes with 
triglycerides and 6 genes with VLDL. The distributions of the number of genes consisting of 
only common variants associated with traits were similar to that of rare variants although the 
number of genes associated with common variants was smaller than the number of genes 
associated with rare variants.  
The literature confirmed many gene-trait associations which were identified in our study. 
Throughout this section, all genes included common variants only in the analysis.  REG1B, 
which showed  the most significant association with the 46 traits (p-value 1161065.1  ), has 
been reported to be associated with glucose71 (our analysis identified an association with p-value 
211031.1  ), the production of insulin72 (our analysis identified an association with insulin 
with p-value 241081.1   and HOMA-IR with p-value 941002.5  ), and triglyceride whose 
increment has deleterious effects on the function of islet beta cells73 (our analysis showed an 
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association with triglyceride with p-value 241081.1  ). LEF1, which was associated with the 
46 traits (p-value 831044.7  ), has been related to insulin resistance74 (the analysis 
demonstrated an association with HOMA-B with p-value 521017.7  ) and heart failure75-77 (the 
analysis showed an association with HsCRP with p-value 1221022.1    and Homocysteine 
with p-value 141024.2  ). DYNC1H1, which was associated with the 46 traits (p-value 
581046.3  ), HOMA-IR (p-value 1081076.4  ), insulin (p-value 281083.2  ), glucose (p-
value 101007.1  ) and creatinine (p-value 91057.2  ), has been associated with 
hyperinsulinemia, hyperglycemia, the progress of glucose intolerance78, and the blood creatinine 
level.79  DOCK7, which presented associations with the 46 traits (p-value 571042.4  ), 
HsCRP (p-value 531066.3  ) and BMI (p-value 71036.9  ), has been associated with heart 
disease and ischemic stroke80 and overweight and obesity.81  Gene GBF1, which was associated 
with the 46 traits (p-value 281030.6  ), HOMA-B (p-value 171091.2  ), has been reported 
to be involved in insulin resistance and type 2 diabetes.82 METAP2, which showed strong 
association with the 46 traits (p-value 201062.2  ), HOMA-B (p-value 321014.3  ), 
HOMA-IR (p-value 171017.3  ) and insulin (p-value 101061.8  ), has demonstrated 
associations with insulin resistance and insulin levels.83  Gene GRN, which presented 
associations with the 46 traits (p-value 161063.1  ), HOMA-IR (p-value 291028.2  ) and 
insulin (p-value 101089.7  ), has been reported to associate with insulin resistance in type 2 
diabetes patients84 and the blood insulin levels.85   Finally, gene USP44, which showed 
associations with the 46 traits (p-value 141049.3  ), HsCRP (p-value 311081.1  ) and 
HOMA-IR (p-value 111075.7  ), has been reported to associate with congenital heart 
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disease86,  the increment of the  HsCRP in congenital heart disease patients87and insulin 
resistance.87  
 
Discussion 
Investigating the pleiotropic effects of the genetic variants can provide important information 
to allow a deeper understanding of the complex genetic structures of health and disease. 
However, the identification of complete pleiotropic structures of high dimensional genotype-
phenotypes poses great statistical and computational challenges. To meet these challenges, we 
have addressed several issues to overcome the critical barriers in advancing the development of 
novel statistical methods and computational algorithms for genetic pleiotropic analysis.  
The first issue is to explore deep architectures of genotype-phenotype data in cross-phenotype 
association analysis. The traditional single trait and multiple trait analysis usually use genotype 
data in their raw form. These methods do not transform the raw data into a suitable internal 
representation in which association analysis can be used for distinguishing disease patterns from 
health patterns. However, the genetic variants include missense, nonsense, silent, insertions and 
deletions, frameshift, gain of function, loss of function, splicing site, transcription factor binding 
site, promotor, enhancer, histone modifications and regulatory motifs.  DNA sequences and 
genetic variants are hierarchically organized in the genome. Exploring multiple levels of 
representation of the genetic variants and learning their internal patterns involved in the disease 
development can increase the power to detect the association of the genetic variants with 
phenotypes. To utilize the deep architectures of genetic variants across the genomic region, we 
proposed a new paradigm of association analysis that consists of three steps to combine 
multilevel data reduction and CCA.  The first step is to apply FPCA to the original data for 
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dimension reduction. The FPCA decomposes the genetic data into several functional 
components. Each functional component contains functional information of genetic variants 
across the genomic region, preserves the orders of genetic variants along the genomic and returns 
all possible pair-wise and high order linkage disequilibrium. If the phenotypes are function-
valued physiological traits or RNA-seq data, the FPCA can also be applied to the phenotype 
data.  The second step is to use quadratically regularized matrix factorization for further 
compressing the FPC scores into low rank representation and removing noisy data points. As a 
result, the FPCA and matrix factorization extracted useful genetic and phenotype information 
and deeply learned the internal genetic and phenotype representation. The third step is to apply 
CCA to the extracted FPC scores.  Large scale simulations and real data analysis demonstrated 
that QRFCCA substantially outperformed all nine other statistics and FCCA outperformed the 
statistics without functional data analysis for data reduction.  
The second issue is to develop a general framework for unifying association analysis, which 
provides a theoretic basis to evaluate various statistical methods for association analysis and 
design the guidance for developing novel statistics for testing the association of genetic variants 
with phenotypes. We used reproducing kernel Hilbert spaces (RKHS) as a general framework 
and the covariance operator as a general tool for unifying CCA, kernel CCA, functional CCA, 
dependence measure-based independence tests and other association analyses including GAMuT. 
We showed that the maximum heritability analysis and multivariate linear regression are 
equivalent to the classical CCA. Covariance is a key measure to assess linear association. Its 
extension to covariance operator provides a tool for quantifying the nonlinear association and 
derives kernel-based dependence measures and independence tests which form the basis for the 
GAMuT test. We also show that the KCCA is quite similar to the kernel independent test.    
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Finally, we considered the FCCA. To unify multivariate association tests and functional 
association tests, we used RKHS as a general framework for the formulation of the functional 
CCA. We showed that the dependence measured in the FPC score-based kernel analysis is 
asymptotically equal to the association measure of the FCCA.  The FCCA also use the kernel-
based dependence measure to develop association tests. Unlike the KCCA and GAMuT test 
where the kernels are selected by users, the FCCA uses the FPC scores as the feature space and 
derives the kernels from the data.  This was why large-scale simulations and real data showed 
that in general, the FCCA outperformed the GAMuT and KCCA.   Our FPC scores were 
generated via two steps. The first step used Fourier or wavelet expansions to derive 
eigenfunctions. The second step was to generate the FPC scores from the eigenfunctions. In the 
literature, some authors used one step FPCA to directly derive FPC scores from the Fourier or 
wavelet expansions. Our experiences showed that the number of functional principal components 
using two step FPCA was, in general, smaller than that directly derived from the Fourier or 
wavelet expansions. Therefore, two step FPCA had higher power than the one step FPCA.   
The third issue is how to reveal pleiotropic structure of the genetic variants and quantify the 
degree of pleiotropy.  Pleiotropy is a widely used word to indicate that a gene affects multiple 
traits. However, the nature and extent of pleiotropy is less precisely defined. Our approach to 
pleiotropy was based on the classical hypothesis-testing framework. We made formal statistical 
tests for the pleiotropy. The null model of the pleiotropy of a gene is the absence of any traits 
which the gene was associated with. The alternative model is the presence of at least one trait 
which the gene was associated with. Under the hypothesis-testing approach, the real data 
analysis showed that the global structure of pleiotropy consisted of three scenarios. The first 
scenario was the presence of a single trait which the gene was significantly associated with at the 
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genome-wide significance level. The second scenario was the presence of multiple traits which 
the gene was significantly associated with at the genome-wide significance level. The third 
scenario was the presence of multiple traits which the gene was weakly associated with. In the 
first two scenarios, in addition to traits which the gene was significantly associated with, some 
traits that did not reach genome-wide level to have significant association with the gene, had 
weak associations with the gene at p-value 05.0 . In genetic pleiotropic studies, if we start with 
searching the genes significantly associated with a single trait at the genome-wide significance 
level, then many genes with pleiotropic effects will be missed. In the UK-10K real data analysis, 
single trait association analysis failed to identify 44 genes (27 genes with rare variants and 17 
genes with common variants) with pleiotropic effects.  
The fourth issue is the cross-phenotype association analysis with next-generation sequencing. 
The popular methods for cross-phenotype association analysis is to assess the influence of a 
single variant on multiple distinct phenotypes. These methods work very well for cross-
phenotype association analysis of common variants, but are not suitable for testing the 
association of rare variants with multiple phenotypes. To illustrate the urgent need to develop 
gene-based statistical methods for cross-phenotype association analysis of rare variants, we 
searched the variants across the genome for significant associations with the multiple 
phenotypes. We found that 21,272  rare variants were significantly associated with the 46  traits 
at the genome-wide significance level after Bonferroni correction.  It is highly unlikely that so 
many rare variants affected the 46 traits. To overcome this limitation, we developed the 
QRFCCA for gene-based cross-phenotype association analysis. The QRFCCA can be applied to 
both multivariate phenotypes, function-valued phenotypes and NGS genotype data. Since the 
genotype profiles of the common variants and rare variants have different patterns, to increase 
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the power of the tests, we take the association tests of common variants and rare variants 
separately. We found that the significant genes with common variants only were not overlapped 
with the significant genes with rare variants only.  In pleiotropic analysis, we should conduct 
cross-phenotype analysis for both common and rare variants and separately. The QRFCCA 
provides a powerful tool to accomplish this task. 
To provide a guidance for cross phenotype association studies, we comprehensively evaluated 
the current existing statistics for cross-phenotype association by using large-scale simulations 
and real data analysis. We found that the proposed QRFCCA not only substantially outperformed 
all other widely used competing statistics, but also was very flexible. The QRFCCA can be used 
for association analysis of both common variants and rare variants, and any phenotypes including 
quantitative or qualitative, multivariate or function-valued phenotypes.  
We performed cross-phenotype association analysis of a largest number of traits with NGS 
data up to the present time. We identified 79 genes including rare variants only which were 
significantly associated with the 46 traits and 67 genes including common variants only which 
were significantly associated with the 46 traits. These two sets of genes were not overlapped. 
Some of gene-phenotype association can be confirmed in the literature. We found that the largest 
number of the traits which a gene significantly affected at the genome-wide significance level 
was six and three in the cross-phenotype association analysis of common and rare variants, 
respectively. We also discovered that the largest number of traits which a gene affected with the 
P-value < 0.05 was 18 and 16 in the cross-phenotype association analysis of common and rare 
variants, respectively. In the single trait association analysis, we found that a large number of 
genes significantly affected creatinine (genes with rare variants: 345, genes with common 
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variants: 34), HsCRP (genes with rare variants: 72, gene with common variants: 29) and HOMA-
IR (genes with rare variants: 108, genes with common variants: 24).  
The results presented in this paper are preliminary. The greatest lengths of the genes that were 
significantly associated with the 46 traits for rare and common variants in the real data analysis 
were 131Kb and 42Kb, respectively. The proposed methods may not have power to detect the 
association of the genes with lengths longer than these numbers.  The number of basis functions 
for genotype profile expansion is an important factor for the power of the FPCA-based tests. We 
have not performed theoretical analysis to determine the appropriate number of basic functions 
for genotype profile expansions. We resort to ad hoc approaches to select the number of basis 
function in the expansions. The current pleiotropic analysis cannot identify the global causal 
structure of pleiotropy, which will decrease our power to unravel mechanisms underlying 
complex traits. To overcome this limitation, causal inference tools should be explored for cross-
phenotype association analysis. The purpose of this paper is to stimulate further discussions 
regarding the great challenges we are facing in the pleiotropy analysis of high dimensional 
phenotypic and genomic data produced by modern sensors and next-generation sequencing. 
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Figure Titles and Legends 
Figure 1. The power of curves as a function of sample sizes of 10 statistics for collectively 
testing the association of all rare variants in the gene with 10 traits with low correlations at the 
significance level 05.0  .  
Figure 2. The power of curves as a function of sample sizes of 10 statistics for collectively 
testing the association of all rare variants in the gene with 10 traits with moderate correlations, 
respectively, at the significance level 05.0  .  
Figure 3. The power of curves as a function of sample sizes of 10 statistics for collectively 
testing the association of all rare variants in the gene with 10 traits with high correlations, 
respectively, at the significance level 05.0  .  
Figure 4. The power of curves as a function of sample sizes of 10 statistics for collectively 
testing the association of the gene including both rare and common variants with 10 traits with 
low correlations at the significance level 05.0  .  
Figure 5. The power of curves as a function of sample sizes of 10 statistics for collectively 
testing the association of the gene including both rare and common variants with 10 traits with 
moderate correlations, respectively, at the significance level 05.0  .  
Figure 6. The power of curves as a function of sample sizes of 10 statistics for collectively 
testing the association of the gene including both rare and common variants with 10 traits with 
high correlations, respectively, at the significance level 05.0  .  
Figure 7. QQ plot of QRFCCA, FCCA, PCA and GAMuT with 95% confidence interval for rare 
variants. The negative logarithm of the observed ( y  axis) and the expected ( x axis) P value is 
plotted for each gene (dot), and the red line indicates the null hypothesis of no true association. 
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Figure 8. Manhattan plot showing the genome-wide P values of association of the genes 
consisting of only rare variants with the 46 traits calculated using QRFCCA. The axis x
represented the chromosomal positions of 33,746 genes and axis y showed their P10log
values. The horizontal red line denotes the thresholds of 61048.1 P  for genome-wide 
significance after Bonferroni correction. 
Figure 9. Cross phenotype association heat map (46 traits/79 genes with rare variants only). The 
horizontal axis denotes the traits and the vertical axis denotes the genes. The color represented P-
values. The smaller the P-value the deeper the red color.  
Figure 10. QQ plot of QRFCCA, FCCA, PCA and GAMuT with 95% confidence interval for 
common variants. The negative logarithm of the observed ( y  axis) and the expected ( x axis) P 
value is plotted for each gene (dot), and the red line indicates the null hypothesis of no true 
association. 
Figure 11. Manhattan plot showing the genome-wide P values of association of the genes 
consisting of only common variants with the 46 traits calculated using QRFCCA. The axis x
represented the chromosomal positions of 33,746 genes and axis y showed their P10log
values. The horizontal red line denotes the thresholds of 61051.1 P  for genome-wide 
significance after Bonferroni correction. 
Figure 12. Cross phenotype association heat map (46 traits/67 genes with common variants 
only). The horizontal axis denotes the traits and the vertical axis denotes the genes. The color 
represented P-values. The smaller the P-value the deeper the red color.  
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Tables 
Table 1. Type 1 error rates of 10 statistics for testing the association of rare variants in a gene 
with 15 highly correlated traits. 
Sample 
Size 
Level MANOVA minP PCA CCA USAT GAMuT FCCA SCCA QRFCCA KCCA 
 0.05 0.0494 0.0284 0.0495 0.0473 0.0399 0.0524 0.0477 0.0513 0.0492 0.0442 
500 0.01 0.0102 0.0058 0.0096 0.097 0.0074 0.0104 0.0097 0.0101 0.0099 0.0095 
 0.001 0.0009 0.0007 0.0010 0.0010 0.0008 0.0010 0.0011 0.0010 0.0011 0.0010 
 0.05 0.0512 0.0253 0.0501 0.0464 0.0595 0.0548 0.0514 0.0477 0.0497 0.0485 
1000 0.01 0.0105 0.0053 0.0095 0.0107 0.0116 0.0106 0.0106 0.0099 0.0099 0.0099 
 0.001 0.0010 0.0005 0.0010 0.0010 0.0011 0.0011 0.0010 0.0011 0.0010 0.0009 
 0.05 0.0497 0.0271 0.0533 0.0496 0.0598 0.0526 0.0461 0.0486 0.0498 0.0417 
2000 0.01 0.0106 0.0050 0.0099 0.0106 0.0123 0.0113 0.0104 0.0098 0.0096 0.0099 
 0.001 0.0010 0.0005 0.0010 0.0009 0.0014 0.0011 0.0010 0.0010 0.0009 0.0009 
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Table 2. Type 1 error rates of 10 statistics for testing the association of both rare and common 
variants in a gene with 15 highly correlated traits. 
Sample 
Size 
Level MANOVA minP PCA CCA USAT GAMuT FCCA SCCA QRFCCA KCCA 
 0.05 0.0497 0.0276 0.0482 0.0473 0.0404 0.0492 0.0519 0.0516 0.0518 0.0490 
500 0.01 0.0094 0.0057 0.0097 0.0100 0.0076 0.0103 0.0105 0.0103 0.0095 0.0104 
 0.001 0.0010 0.0006 0.0010 0.0010 0.0008 0.0010 0.0009 0.0009 0.0010 0.0009 
 0.05 0.0484 0.0280 0.0495 0.0513 0.0579 0.0550 0.0467 0.0522 0.0503 0.0442 
1000 0.01 0.0095 0.0055 0.0099 0.0097 0.0109 0.0105 0.0099 0.0099 0.0097 0.0096 
 0.001 0.0010 0.0005 0.0010 0.0011 0.0012 0.0011 0.0010 0.0010 0.0010 0.0009 
 0.05 0.0517 0.0266 0.0479 0.0534 0.0694 0.0556 0.0512 0.0530 0.0500 0.0481 
2000 0.01 0.0099 0.0052 0.0096 0.0106 0.0125 0.0113 0.0096 0.0098 0.0102 0.0096 
 0.001 0.0010 0.0005 0.0010 0.0010 0.0012 0.0011 0.0010 0.0010 0.0010 0.0010 
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Table 3. A list of P-valuesof 25 genes with rare variants only significantly associated with 46 traits using QRFCCA. 
    Statistical Methods 
Gene Chr QFCCA FCCA SCCA PCA KCCA GAMuT USAT CCA MANOVA 
CTC-
498M16.2 5 5.7E-22 2.9E-19 1.3E-03 2.6E-01 1.2E-06 1.9E-02 9.3E-01 4.7E-02 1.5E-02 
TRAJ22 14 2.2E-20 7.2E-18 1.0E-06 1.5E-12 8.6E-07 1.0E-05 8.6E-01 3.6E-01 2.6E-01 
AP000351.10 22 2.1E-18 3.9E-16 1.9E-03 7.4E-01 1.3E-06 2.5E-02 6.8E-01 2.8E-01 1.7E-01 
HAR1B 20 7.8E-18 2.5E-15 1.0E-06 8.3E-02 3.1E-01 2.3E-01 8.4E-01 9.5E-01 9.9E-01 
IGHVII-20-1 14 7.5E-16 1.9E-15 1.2E-03 2.2E-01 4.5E-03 1.1E-01 9.5E-01 3.5E-01 1.1E-01 
RP11-4F5.2 15 9.9E-16 6.1E-13 2.1E-03 9.9E-01 3.6E-01 1.2E-04 9.7E-01 7.2E-01 4.7E-01 
RNVU1-17 1 3.9E-13 4.8E-13 1.2E-03 5.5E-02 3.0E-01 6.0E-06 8.2E-01 9.9E-01 7.4E-01 
PNOC 8 1.6E-12 2.9E-12 1.0E-06 7.5E-01 3.1E-01 5.4E-05 8.8E-01 9.0E-02 3.9E-03 
COTL1P1 17 8.7E-12 1.4E-11 7.5E-04 6.2E-01 3.2E-06 5.4E-03 8.2E-01 1.5E-02 2.0E-03 
LINC00273 16 4.4E-11 1.8E-09 9.0E-04 6.5E-12 2.9E-03 1.7E-05 8.2E-01 7.1E-05 9.1E-06 
snoU13 12 5.0E-11 1.3E-10 6.9E-03 9.8E-01 1.1E-02 9.0E-03 8.7E-01 5.8E-01 2.2E-01 
ADAM19 5 6.1E-11 8.6E-09 1.0E-06 1.2E-01 6.9E-01 8.2E-01 8.8E-01 9.5E-01 9.7E-01 
CTD-
2026G6.2 3 1.9E-10 9.3E-10 2.3E-03 6.4E-02 4.1E-01 3.2E-02 9.8E-01 9.3E-01 9.3E-01 
MIR409 14 2.8E-10 5.4E-10 4.1E-04 2.1E-03 5.1E-03 1.3E-01 1.0E+00 2.0E-02 8.9E-04 
RP1-
276E15.1 11 3.1E-10 4.6E-10 5.2E-03 4.3E-01 8.5E-01 6.1E-03 8.7E-01 9.7E-01 9.5E-01 
HMGN1P6 2 4.5E-10 3.8E-08 1.0E-02 1.2E-02 4.7E-01 8.3E-06 8.2E-01 9.3E-01 9.8E-01 
HOXA7 7 2.2E-09 3.2E-09 1.0E-06 7.2E-01 9.9E-03 8.8E-02 9.4E-01 8.0E-01 4.2E-01 
RNA5SP99 2 2.4E-09 1.4E-09 2.1E-04 8.3E-01 6.5E-01 6.3E-04 9.4E-01 9.8E-01 6.9E-01 
AC021660.1 3 2.7E-09 2.5E-09 1.8E-04 1.3E-01 9.7E-01 7.8E-06 7.7E-01 4.4E-01 6.6E-02 
RP11-
561N12.1 7 3.1E-09 9.1E-08 1.1E-04 2.1E-02 3.0E-01 5.5E-06 8.9E-01 8.4E-01 2.4E-01 
FBXL5 4 4.5E-09 9.9E-08 6.8E-04 9.2E-03 3.5E-01 6.6E-06 9.9E-01 9.9E-01 9.2E-01 
PPIAP23 13 5.4E-09 5.5E-09 4.3E-04 2.9E-05 4.0E-01 1.7E-05 1.0E+00 4.2E-01 5.3E-02 
HOXB2 17 7.0E-09 2.2E-09 1.0E-06 2.4E-02 6.3E-01 9.5E-06 1.0E+00 9.1E-01 8.4E-01 
RP11-
170N16.1 4 7.1E-09 3.6E-07 6.2E-03 5.5E-05 9.4E-01 6.0E-04 1.0E+00 9.4E-01 9.2E-01 
AC008694.3 5 1.4E-08 5.0E-07 1.4E-03 1.1E-05 8.8E-01 2.4E-06 9.6E-01 9.9E-01 9.3E-01 
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Table 4. A list of P-value of 25 genes with common variants only significantly associated with 46 traits using 
QRFCCA.  
    Statistical Methods 
Gene Chr QRFCCA FCCA GAMuT SCCA USAT MANOVA CCA PCA KCCA 
REG1B 2 1.6E-116 7.4E-113 4.3E-01 1.3E-03 5.2E-01 1.0E+00 9.2E-01 3.0E-02 9.6E-01 
RP11-
665C14.1 
4 1.4E-93 8.2E-75 3.0E-01 4.6E-04 2.6E-01 9.8E-01 1.0E+00 3.9E-01 9.5E-01 
ZNF160 19 2.0E-91 6.7E-84 4.8E-02 5.6E-05 3.1E-01 9.0E-01 9.4E-01 1.3E-01 9.6E-01 
LEF1 4 7.4E-83 1.8E-82 2.8E-03 1.0E-06 7.0E-01 9.5E-01 9.7E-01 2.3E-03 9.9E-01 
DYNC1H1 14 3.5E-58 4.2E-48 5.4E-02 4.1E-03 6.6E-01 9.2E-01 9.4E-01 5.4E-01 9.4E-01 
DOCK7 1 4.4E-51 6.9E-50 1.7E-01 8.0E-06 9.4E-01 9.1E-01 9.7E-01 1.2E-01 9.5E-01 
SHC3 9 7.6E-42 2.2E-41 1.4E-02 4.2E-05 8.7E-02 9.7E-01 9.4E-01 1.3E-01 9.9E-01 
Y_RNA 7 1.9E-36 1.3E-29 4.0E-03 3.5E-05 4.5E-01 1.0E+00 1.0E+00 7.9E-01 9.7E-01 
CTD-
2122P11.1 
5 1.6E-33 2.9E-31 7.4E-01 1.5E-05 2.3E-01 9.7E-01 9.8E-01 5.3E-01 9.9E-01 
GBF1 10 6.3E-28 2.3E-28 6.5E-02 4.5E-04 9.7E-01 9.7E-01 9.7E-01 8.4E-02 9.0E-01 
RP1-8B22.1 1 1.7E-27 4.1E-26 3.0E-02 7.3E-04 1.8E-01 1.0E+00 1.0E+00 5.0E-02 9.2E-01 
VPS13D 1 2.6E-26 1.5E-27 7.9E-01 1.9E-03 8.6E-01 9.8E-01 1.0E+00 8.9E-01 9.4E-01 
RP11-68I3.2 17 3.2E-24 4.9E-24 2.2E-01 1.5E-05 1.0E+00 9.0E-01 9.6E-01 1.6E-02 9.9E-01 
SLC13A3 20 8.5E-24 2.0E-24 5.3E-01 9.0E-06 4.2E-01 9.9E-01 9.3E-01 7.9E-02 9.4E-01 
RP11-
167N24.3 
12 4.3E-23 1.0E-22 7.8E-01 1.1E-03 2.1E-01 9.2E-01 9.2E-01 6.3E-01 9.8E-01 
UBA6 4 5.3E-22 4.8E-22 2.0E-01 1.2E-03 4.9E-01 9.0E-01 1.0E+00 2.8E-01 9.2E-01 
GAN 16 1.5E-21 1.0E-20 7.3E-02 3.0E-05 6.6E-01 9.7E-01 9.3E-01 2.9E-01 9.6E-01 
RP4-794H19.2 1 4.1E-21 1.3E-20 7.5E-01 1.6E-04 8.2E-02 9.3E-01 1.0E+00 9.1E-01 9.5E-01 
RP11-142I20.1 18 5.3E-21 8.5E-21 1.5E-01 4.3E-05 8.9E-01 9.3E-01 9.9E-01 3.4E-01 9.5E-01 
METAP2 12 2.6E-20 1.6E-20 6.8E-01 2.5E-05 5.2E-01 9.6E-01 9.4E-01 4.4E-01 9.4E-01 
SLCO1C1 12 5.9E-20 1.7E-19 7.5E-01 4.0E-06 3.8E-01 9.9E-01 9.1E-01 5.5E-02 9.1E-01 
AC105443.2 7 2.5E-17 3.4E-17 5.6E-02 1.2E-04 2.5E-01 9.6E-01 9.7E-01 2.6E-02 9.8E-01 
GRN 17 1.6E-16 7.8E-16 5.0E-01 1.0E-03 1.2E-01 1.0E+00 1.0E+00 3.5E-02 9.6E-01 
INTS12 4 1.7E-16 1.2E-16 1.8E-02 1.0E-06 4.8E-01 9.7E-01 9.6E-01 3.3E-01 9.5E-01 
RP11-323I15.5 15 9.3E-16 2.0E-16 1.6E-01 5.0E-06 6.7E-01 9.7E-01 9.5E-01 3.5E-01 9.1E-01 
Supplemental Note 
Supplemental Note A 
Quantitative Genetics for Multiple Traits 
Single Trait 
     We first review quantitative genetics for a single trait. For simplicity, we only consider 
genetic additive effects. It is straightforward to extend analysis to include the genetic dominance 
effects.  Consider the genetic model for a trait and a single locus: 
  XY ,           (N1) 
where Y denotes a trait, X an additive genotype score,  the genetic additive effect and  error 
with mean zero and variance 
2
e . 
The genetic additive effect is estimated by 
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respectively. 
Equation (N4) shows that the narrow heritability can also be expressed as the proportion of the 
phenotype variation explained by the genetic variation or the squared correlation between the 
genotype and phenotype. 
Multiple Traits 
     Quantitative genetics for a single trait can be easily extended to multiple traits. Again 
consider a genetic model for multiple traits and multiple loci: 
EXBY  ,          (N5) 
where ],...,[ 1 kYYY   represent a vector of k phenotype variables, X is a vector of p genotype 
variables, 
p
jk RbbbB  ],,...,[ 1 the matrix of genetic additive effects and ],...,[ 1 k   is a 
vector of k error variables.  
The genetic effect matrix B can be estimated by 
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The covariance of the genetic additive effects is defined as 
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The concept of heritability for a single trait is well developed. Recently, there has been an 
increasing attempt to extend heritability from a single trait to multiple traits.  However, their 
focus is to consider the heritability of a linear combination of multiple traits.50,59,60 Here, we 
consider a heritability matrix that is defined as 
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It is clear that the heritability matrix 
2
mh is equal to the matrix 
2R in equation (N8).  
Linear Combination of Multiple Traits 
We consider a linear combination of multiple phenotypes Yb and a linear combination of 
genotypes at multiple loci Xa to transform the association analysis of multiple traits to the 
association analysis of single trait. Define the linear genetic model for Yb  and Xa : 
  )(XaYb .         (N9) 
The total genetic effect of the multiple genotypes on the multiple traits can be estimated by 
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Using equations (N3) and (N4), we obtain the genetic additive variance  of Xa   and heritability 
of yb : 
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respectively.  
It is clear that the squared multiple correlation coefficient is given by 
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Next we seek the optimal combinations of the genotypes at multiple loci and the multiple traits to 
maximize the genetic additive effect, genetic additive variance and heritability. We first find the 
maximum genetic additive effect. 
   Using equation (N10) and the Lagrangian multiplier method, we can solve the following 
optimization problem to obtain the maximum genetic additive effect:50  
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where  is a multiplier. 
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Suppose that the SVD of the matrix xyxx
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is given by 
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Then, it follows from equation (N15) that a ,b  and the optimal genetic effect are the left, right  
singular vectors  and singular value of  xyxx
1
, respectively. Similarly, we can show that the 
genetic additive variance 
2
Al  is the square of the singular value of xyxx
1
. The maximum 
heritability can be obtained by setting the Lagrange function: 
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       (N16) 
Let  
2/12/1   yyxyxxK  and SVD of K be 
T
KKKyyxyxx VU 
 2/12/1
.        (N17) 
Solving equation (N16) we obtain  
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          (N18) 
where ku , kv  and K are the left, right singular vectors and singular value of the matrix K , 
respectively.  Substituting equation (N18) into equations (N10) and (N11) gives 
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KKvu           (N19) 
Note that 
2
K is the eigenvalue of the matrix 
2/112/1   yyxyxxyxyy
TKK .        (N20) 
It follows from equation (N20) and (18) that 
2RKKT  .  
This shows that the maximum heritability analysis is equivalent to CCA.  
Supplemental Note B 
RKHS framework for Functional CCA, Cross-covariance operator, Dependence Measure 
and Independence Test 
Many multivariate and functional statistical methods such as regression, CCA, kernel regression, 
kernel CCA, functional regression and functional CCA, dependence measure can be used to test 
the association of genetic variants with the phenotypes. In the past decades, reproducing kernel 
Hilbert spaces (RKHS) have emerged as a general framework for various statistical and machine 
learning methods. Here, we propose to use RKHS as a unified framework for association tests to 
reveal the relationships among various multivariate and functional association tests. 
We begin with briefly introducing RKHS.1,2  Let H be a Hilbert space of functions on a non-
empty set   and denote the inner product in H by H .,. .  A bivariate function K on   is 
called a reproducing kernel for H if K satisfies 
(1) For every t , H)(., tK and 
(2) For every t  and 𝑓 ∈ ℋ, we have H )(.,,)( tkftf . 
We call H a RKHS with reproducing kernel K . 
     Two approaches can be used to construct a RKHS. The first approach is by completion of the 
space of all functions of the form )(.,
1 i
n
i i
sK   , ,...,2,1,,  nsR ii  with the inner 
product defined as 
      
n
i
l
j jiji
n
i
l
j jjii
tsKtKsK
1 11 1
),()(.,),(.,  H(K) .   (N21) 
The constructed RKHS with reproducing kernel K  is denoted by H(K) . 
The second approach is via completion of the set of all linear combinations of random 
variables.  Consider a stochastic process }:)({ ttX  with mean zero where )(tX denotes a 
map from a probability space into R  and 0)]([ tXE for all t . We define 
2
XL  as the 
completion of the set of all linear combinations of the random variables of the form: 
  
n
i iiii
ntRtX
1
,...,2,1,,),(        (N22) 
with the inner product )]()([)(),( 2 sXtXEsXtX
XL
 .   
Let )]()([),( tXsXEtsK   be a covariance function which generates a RKHS. Two 
approaches can be connected by the inner product: 
.||)(.,||
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    (N23) 
A powerful analytical tool for CCA and independence tests is the cross-covariance operator that 
is an extension of the covariance matrix to infinite dimensional space.3 Recall that the covariance 
matrix is defined as 
][
~ T
XY XYE ,         (N24) 
 where X and Y are vectors of random variables with 0][ XE and 0][ YE . Equation (N24) 
can be extended to feature space.  Let )(X and )(Y be feature maps. In the feature space, 
equation (N24) can be written as 
)]()([
~
YXE TXY  .        (N25) 
Let f and g be vectors in the feature space. Recall that by the reproducing property, we have 
 )(.,(.),)( XKfXf  and  )(.,(.),)( YKgYg .   (N26) 
Define kernels )()(., XXK   and )()(., YYK  .Viewing the covariance matrix XY
~
as an 
operator and applying it to the vector g , we obtain 
)].()([
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gYKXEgYXEg TXY






   (N27) 
Equation (N27) indicates that gXY
~
maps g to a vector in the feature space spanned by )(X . 
Let f  be a vector in the feature space. Then, its inner product with gXY
~
is given by 
)].()(([
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)]()([
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YgXfE
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T
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.     (N28) 
In terms of kernels, equation (N28) can be written as 
](.),.),()(.,(.),[
~
 gYKXKfEgf XY
T
.    (N29) 
We assume that 
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m
j jj
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1
)( .     (N30) 
From equations (N27) and (N28) we can obtain the sampling formula for gf XY
T
~
: 
  
m
i iiXY
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.    (N31) 
Substituting equation (N30) into equation (N31) gives 
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where 
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Let 
mm
m
IG 1
1
 , where m1 is a mm   matrix of ones. The centered covariance is 
T
YXXYXY 
~
, 
where )]([ XEX    and )]([ YEY   . 
Using the similar arguments, we can show 
 yx
T
XY
T KK
m
gf
~~1
 ,       (N33) 
where GGKK xx 
~
 and GGKK yy 
~
. 
The covariance operator is a useful tool for assessing dependence between variables and hence 
form a foundation for association analysis.  A dependence measure can be derived from solving 
the following optimization problem: 
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Let 
2/1~
xKu  and 
2/~
yKv  . Then, the optimization problem (N34) can be transformed to 
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m
1
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T
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vu
        (N35) 
Using the Lagrange multiplier approach to solve the optimization problem, we can obtain the 
eigenequation: 
uvKK
m
yyxx 
2/12/1 ~~1 ,         (N36) 
vuKK
m
xxyy 
2/12/1 ~~1 .         (N37) 
Substituting equation (N37) into equation (N36) gives eigenequation: 
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m
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Assume that the single value decomposition of 
2/12/1 ~~
yyxx KK is 
T
yyxx VUKK 
2/12/1 ~~
,         (N38) 
where ),...,,(diag 21 m  with m  ...21 . 
After some algebra, we obtain 
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It is clear that  )
~~
( Trace
1
2 yyxx
KK
m
can be used as a measure of dependence. The dependence 
measure )
~~
( Trace
1
2 yyxx
KK
m
is used to test for dependence between two sets of random variables4 
and to test for the association of genetic variants with multiple phenotypes.5   
     Consider Kernel CCA (KCCA).9  Let 
T
mXXX )](),...,([)( 1  and 
T
mYYY )](),...,([)( 1  . The representation of linear combinations of the sampled features in 
the feature space can be defined as  
GXU T )(  and GYV
T )( . 
The canonical variates are linear combinations of features and hence can be represented by 
 x
T KGXXGUXGa
~
)()()(   and  y
T KGYYGVYGb
~
)()()(  , 
where GXXGK
T
x )()(
~
 and GYYGK
T
y )()(
~
 . The covariance  between the 
canonical variates a and b is  yx
T KKba
~~
),cov(  . Similarly, we can obtain the variance of 
a  and the variance of b , respectively,  xx
T KKa
~~
)var(   and  yy
T KKb
~~
)var(  . The 
KCCA seeks canonical vectors in terms of  and  to optimize 
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If the constraints in (N40) are replaced by 1
~
)(   x
TKUVar and 1
~
)var(   y
TKV , the 
optimization problem (N40) can be reduced to 
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which is exactly the same as the formulation (N34).  Similar to equation (22),  the association 
measure in the KCCA is equal to 
)ˆˆ( Trace
1
)(Tr
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2
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2 yyxx
KK
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 .      (N42) 
     To unify multivariate association tests and functional association tests, we use RKHS as a 
general framework for formulation of the functional CCA.1 Consider two index sets 
1E and 2E , 
and two stochastic processes: }),({ 1EttX  and }),({ 2EssY   with mean zero 
0)](()]([  sYEtXE for all st, , auto covariance functions  
)),(),(cov(),( 2121 sXsXssRX    ))(),(cov(),( 2121 tYtYttRY   and cross covariance functions 
))(),(cov(),( tYsXtsRXY  . 
Let 
2
XL and 
2
YL be the Hilbert spaces spanned by the X and Y processes defined as the completion 
of the set of all linear combinations of the random variables: 
   
n
i iiii
ZnREttXaa
1 1
,,),(:   and 
   
n
i iiii
ZnREssXbb
1 2
,,),(:   under the inner product ][, 2121 2 aaEaa
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 and 
][, 2121 2 bbEbb
YL
 , respectively.  The covariance kernel can be used to define an integral 
operator: 
 T XX dssstRtR )(),())((   .       (N43) 
By Mercer’s theorem6, the covariance kernel function can be expanded in terms of orthonormal 
functions: 
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where  
)())(( ttR iiiX    and 
)())(( ttR jjjY   . 
Using the Karhunen-Loeve representation, the stochastic processes )(tX and )(tY can be 
expressed as1   
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ttX ii i


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

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1
)()(
j jj
ttY  ,      (N46) 
where  i and j are uncorrelated variables with zero means, and variances and covariance 
jjii   )var(,)var( , ijji  ),cov( ,       (N47) 
which implies 
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The RKHS )( XRH  generated by the covariance kernel XR is
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Similarly, we can define 
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The congruence mapping from )( XRH to 
2
XL is then given by
7 
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Similarly, we define 
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Using equations (N51) and (N52), we obtain 
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By definition of the inner product in the )(
2 TL space, we have 
 T iTLi dtttXX )()(, )(2   and  T jTLj dtttYY )()(, )(2  .   (N54) 
Then, using stochastic integral theory,8  we can connect the covariance between these two inner 
products with the covariance operator: 
  T T jXYiTLjTLi dsdtttsRsYX )(),()(),,,cov( )()( 22  .   (N55) 
Substituting equation (N55) into equation (N53) gives  
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  (N56) 
Substituting equation (N46) into equation (N56) yields 
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where 
XYR with the property   T TLXYXYXY tRdsstsRtR )(2(.)),(.,)(),())((  is a cross 
covariance operator. Equation (N57) is an extension of equation (N28) to functional space.  
     Now we formally define CCA for the stochastic process.  The canonical correlation can be 
defined in terms of both 
2
XL and 
2
YL , and )( XRH and )( YRH : 
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Now we consider the direct extension of the CCA from multivariate to functional space. Suppose 
that expansions of the two functions )(s and )(t in terms of orthonormal functions 
,...}2,1),({ isi and ,...}2,1),({ jtj are given by 
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Define the inner product of functions )(s with stochastic process )(sX  as 
 TTL dssXssXs )()()(),( )(2  .       (N60) 
Substituting equation (N43) into equation (N60), we obtain 
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where   T ii dsss )()(  . 
Similarly, we have  




1)(
2)(),(
j jjTL
tYt  ,  T jj dttt )()(  .     (N62) 
Similar to multivariate CCA where we consider the correlation between linear combinations of 
variables in two sets, the functional CCA consider extensions of linear combinations of the 
random variables to the functional space. Using equations (N48), (N61) and (N62) we calculate 
the covariance: 
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Similarly, we have  
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Therefore, the FCCA can be defined as 
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Comparing equation (N63) with equation (N56) gives 
 T YXT dttYtdssXs ))(),(cov())()(,)()(cov(  .  
This shows that the formulation of FCCA in equation (N65) is equivalent to the formulation of 
the FCCA in the 
22 , YX LL  and )(),( YX RR HH as expressed in equation (N58). Recall that 
112/12   YYXYXXYXYYR . 
After some algebra, we obtain the association measure r in equation (22) : 
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If constraints 1,1   YY
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i.e., the optimization problem (N65) is reduced to 
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 then equation (N66) is reduced to 
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Assume that the expansion of )(tX and )(tY  in equation (N46) are truncated by p and q terms, 
respectively. Define the  feature maps: 
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T
iqiiiY   ],...,,[)( 21 , where ik and il are the FPC 
score of )(tX i and )(tYi , respectively. 
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Define kernel Gram matrices )()( XXK
T
xx  and )()( YYK
T
yy  . The dependence 
measure is 
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Note that 
T
 asymptotically converges to XY
TE ][  . Therefore, the dependence measure 
YXD asymptotically converges to  
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1
     . In other words, the dependence measure is 
asymptotically equal to the association measure of the FCCA.  
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